Lovastatin enhances in vitro radiation-induced apoptosis of rat B-cell lymphoma cells.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of experimental & clinical cancer research : CR

• Publication date

  2005-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 15943032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA damage checkpoint control in cells exposed to ionizing radiation

  2003cited by this paper
• Cell adhesion to the extracellular matrix protein fibronectin modulates radiation-dependent G2 phase arrest involving integrin-linked kinase (ILK) and glycogen synthase kinase-3β (GSK-3β) in vitro

  2003cited by this paper
• Lovastatin causes sensitization of HeLa cells to ionizing radiation‐induced apoptosis by the abrogation of G2 blockage

  2003cited by this paper
• The Ras family of GTPases in cancer cell invasion

  2000cited by this paper
• Inhibition of ras oncogene: a novel approach to antineoplastic therapy.

  2000cited by this paper
• Ras proteins in the control of the cell cycle and cell differentiation

  2000cited by this paper
• RAS and leukemia: from basic mechanisms to gene-directed therapy.

  1999cited by this paper
• Inhibitory effect of Lovastatin on spontaneous metastases derived from a rat lymphoma

  1999cited by this paper
• Lovastatin Inhibits Tumor Growth and Metastasis Development of a Rat Fibrosarcoma

  1998cited by this paper
• Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure.

  1998cited by this paper
• A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme.

  1998cited by this paper
• The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.

  1997cited by this paper
• Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling.

  1997cited by this paper
• Mevalonic Acid Is Limiting for N-Linked Glycosylation and Translocation of the Insulin-like Growth Factor-1 Receptor to the Cell Surface

  1996cited by this paper
• Lipid Metabolism as a Target for Brain Cancer Therapy: Synergistic Activity of Lovastatin and Sodium Phenylacetate Against Human Glioma Cells

  1996cited by this paper
• Effect of lovastatin alone and as an adjuvant chemotherapeutic agent on hepatoma tissue culture-4 cell growth

  1995cited by this paper
• In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin.

  1995cited by this paper
• Lovastatin Inhibits Pancreatic Cancer Growth Regardless of RAS Mutation

  1994cited by this paper
• Selective inhibition of primary acute myeloid leukaemia cell growth by lovastatin.

  1994cited by this paper
• Characterization of the response of growth and differentiation to lipoproteins and agents affecting cholesterol metabolism in murine neuroblastoma cells

  1994cited by this paper
• Inhibition of isoprenoid biosynthesis induces apoptosis in human promyelocytic HL-60 cells.

  1994cited by this paper
• Increased radioresistance of ejras‐transformed human osteosarcoma cells and its modulation by lovastatin, an inhibitor of p21ras isoprenylation

  1993influential reference
• Differences in radiation-induced micronuclei yields of human cells: influence of ras gene expression and protein localization.

  1993cited by this paper
• Posttranscriptional control of thymidine kinase messenger RNA accumulation in cells released from G0-G1 phase blocks.

  1993cited by this paper
• Requirement for mevalonate in the control of proliferation of human breast cancer cells.

  1992cited by this paper
• Inhibition of pancreatic adenocarcinoma cell growth by lovastatin.

  1992cited by this paper
• In vivo regulation of human leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase: increased enzyme protein concentration and catalytic efficiency in human leukemia and lymphoma.

  1991cited by this paper
• Cell cycle-specific effects of lovastatin.

  1991cited by this paper
• Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin.

  1991cited by this paper
• Increase in the active form of 3-hydroxy-3-methylglutaryl coenzyme A reductase in human hepatocellular carcinoma: possible mechanism for alteration of cholesterol biosynthesis.

  1990cited by this paper
• Regulation of the mevalonate pathway

  1990cited by this paper
• Efficacy and long-term adverse effect pattern of lovastatin.

  1988cited by this paper
• Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

  1985cited by this paper
• Altered activation state of hydroxymethylglutaryl-coenzyme A reductase in liver tumors.

  1983cited by this paper
• [Genetic analysis of the resistance to tumor development in an inbred strain of rats].

  1983cited by this paper
• Essential role for mevalonate synthesis in DNA replication.

  1979cited by this paper

• Unveiling the potential benefits of statins in medulloblastoma treatment: A promising therapeutic approach

  2025cites this paper
• Simvastatin Inhibits Tumor Growth and Migration by Mediating Caspase-1-dependent Pyroptosis in Glioblastoma Multiforme.

  2022cites this paper
• Targeting the Tumor Microenvironment: A Literature Review of the Novel Anti-Tumor Mechanism of Statins

  2021cites this paper
• Pleiotropic effects of statins: a focus on cancer.

  2020cites this paper
• Atorvastatin in combination with radiotherapy and temozolomide for glioblastoma: a prospective phase II study

  2020cites this paper
• Statins: a new approach to combat temozolomide chemoresistance in glioblastoma

  2018cites this paper
• Associations between statin use and non‐Hodgkin lymphoma (NHL) risk and survival: a meta‐analysis

  2017cites this paper
• Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina

  2016cites this paper
• Statins are potential anticancerous agents (review).

  2015cites this paper
• Lovastatin inhibits human B lymphoma cell proliferation by reducing intracellular ROS and TRPC6 expression.

  2014cites this paper
• Anticancer properties of Monascus metabolites

  2014cites this paper
• Statin use and the risk of recurrence after radical prostatectomy in a cohort of men with inherited and/or early-onset forms of prostate cancer.

  2014cites this paper
• Epidemiologic Approaches to Understanding Advanced Prostate Cancer: Chemoprevention, Genetics and Response to Therapy.

  2012cites this paper
• Statin use and risk of prostate cancer recurrence in men treated with radiation therapy.

  2010cites this paper
• Role of the Mevalonate Pathway in Tocotrienol-Mediated Tumor Suppression

  2008cites this paper
• Simvastatin impairs humoral and cell‐mediated immunity in mice by inhibiting lymphocyte homing, T‐cell activation and antigen cross‐presentation

  2008cites this paper
• Emerging indications for statins: a pluripotent family of agents with several potential applications.

  2007cites this paper
• Statin Use and Cancer Risk: An Epidemiologic Review

  2006cites this paper